Appendix 4D
| Stock | Pro Medicus Ltd (PME.ASX) |
|---|---|
| Release Time | 13 Feb 2025, 9:28 a.m. |
| Price Sensitive | Yes |
Pro Medicus Reports 42.7% Rise in Half-Year Profit
- Revenue from contracts with customers up 31.1% to A$97.19 million
- Underlying profit before tax up 42.9% to A$69.93 million
- Reported profit before tax up 46.1% to A$73.27 million
Pro Medicus Limited, a leading provider of medical imaging software and services, has released its Appendix 4D Half-Year Report for the financial half-year ended 31 December 2024. The company has reported a robust financial performance, with revenue from contracts with customers increasing by 31.1% to A$97.19 million, compared to the previous corresponding period. Underlying profit before tax, excluding currency gains/losses and fair value movement of other financial assets, grew by 42.9% to A$69.93 million. Reported profit before tax, including these items, increased by 46.1% to A$73.27 million. Profit from ordinary activities after tax attributable to members rose by 42.7% to A$51.75 million. The company has also announced an interim dividend of 25.0 cents per share, fully franked, to be paid on 21 March 2025.
The company has not provided any high-importance, price-sensitive forward-looking financial metrics in the announcement.
The company has not provided any forward-looking outlook statements in the announcement.